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Dysfunction in Ataxia-telangiectasia mutated (ATM),
a central component of the DNA repair machinery, re-
sults in Ataxia Telangiectasia (AT), a cancer-prone
diseasewith a variety of inflammatorymanifestations.
By analyzing AT patient samples and Atm/ mice,
we found that unrepaired DNA lesions induce type I
interferons (IFNs), resulting in enhanced anti-viral
and anti-bacterial responses in Atm/ mice. Priming
of the type I interferon system by DNA damage in-
volved release of DNA into the cytoplasm where it
activated the cytosolic DNA sensing STING-mediated
pathway, which in turn enhanced responses to innate
stimuli by activating the expression of Toll-like recep-
tors, RIG-I-like receptors, cytoplasmic DNA sensors,
and their downstream signaling partners. This study
provides a potential explanation for the inflammatory
phenotype of AT patients and establishes damaged
DNA as a cell intrinsic danger signal that primes the
innate immune system for a rapid and amplified
response to microbial and environmental threats.
INTRODUCTION
Type I interferons (IFNs), the main effector cytokines against viral
infections, are inducedmainly via the activation of pattern-recog-
nition receptors (PRRs) such as Toll-like receptors (TLRs), RIG-I-
like receptors (RLRs), and the newly identified STING-dependent
pathways that recognize microbial and self-DNA, as well as cy-
clic dinucleotides in the cytoplasm (Kumar et al., 2011; Paludan
andBowie, 2013). Although produced in large amounts during in-
fections, it has long been acknowledged that type I IFNs are also
produced spontaneously albeit at very low levels in the absence
of infection (Lienenklaus et al., 2009). Such constitutively pro-
duced type I IFNs play a vital role in priming and maintaining332 Immunity 42, 332–343, February 17, 2015 ª2015 Elsevier Inc.the innate immune system in a ‘‘ready to go’’ state for prompt
response upon microbial encounter (Hata et al., 2001; Taniguchi
and Takaoka, 2001). Consequently, subtle changes in constitu-
tive production of type I IFNs can have profound effects on the
magnitude and quality of immune response elicited by microbes
or other environmental danger signals (Gough et al., 2012; Hata
et al., 2001; Taniguchi and Takaoka, 2001). Accordingly, if
chronic, elevated constitutive type I IFNs might contribute to un-
desirable inflammatory responses and possibly autoimmunity
(Arakura et al., 2007; Gough et al., 2012; Taniguchi and Takaoka,
2001). The molecular events underlying constitutive type I IFN in-
duction and how defects in such events impact the onset and
progression of disease remain unclear.
DNA damage is a constant threat to all eukaryotic life. DNA
damage can be a result of exogenous genotoxic agents such
as irradiation, UV light, or chemical mutagens or due to endoge-
nous genotoxic events such as DNA replication, recombination
errors, metabolic genotoxins, or oxidative stress. Of the various
forms of damages inflicted by these mutagens, double-strand
breaks (DSB) of DNA are the most toxic form. Ataxia-telangiec-
tasia mutated (ATM) kinase plays a central role in double-strand
DNA repair. In humans, loss of function mutations in ATM results
in Ataxia Telangiectasia (AT), a complex cancer-prone neurode-
generative disease that displays a variety of inflammatory and
autoimmune syndromes whose etiology remains unclear (Am-
mann and Hong, 1971; Deng et al., 2005; Kutukculer and Aksu,
2000; McGrath-Morrow et al., 2010; Shao et al., 2009; West-
brook and Schiestl, 2010). Furthermore, AT is associated with
a peculiar susceptibility to respiratory bacterial infections (Boder
and Sedgwick, 1958; Nowak-Wegrzyn et al., 2004; Schroeder
and Zielen, 2013) and chronic herpes virus infections (Kulinski
et al., 2012; Masucci et al., 1984). Whereas such infections are
presumed to be a result of defects in the adaptive immune sys-
tem, curiously, severe systemic viral infections are dispropor-
tionately uncommon in such patients (Boder and Sedgwick,
1958; Nowak-Wegrzyn et al., 2004; Schroeder and Zielen,
2013). Whether ATM dysfunctions affect the innate immune sys-
tem and whether that might contribute to AT associated features
has not been addressed.
Here we show that accumulation of spontaneous DNA lesions
in the absence of ATM or in response to exogenous genotoxic
stress induces type I IFNs and that this primes the innate immune
system for an amplified type I IFN response upon viral and bac-
terial encounter. We show that DNA damage induced type I IFN
production is due to activation of STING pathway by self-DNA
released into the cytoplasm.
RESULTS
Loss of ATM Function Results in a Spontaneous Type I
Interferon Response
While analyzing the role of ATM in innate immunity, we observed
that sera from infection-free AT patients could protect HEK293
cells against the RNA virus Vesicular stomatitis virus (VSV-GFP)
(Figures 1A and 1B). The sera could activate expression of the
interferon stimulated geneMx1 and nuclear factor-kB (NF-kB) re-
sponses in HEK293 luciferase reporter cells (Figures 1C and 1D),
indicating that ATM deficiency in human results in spontaneous
systemic inflammation.We next analyzed fibroblasts fromAT pa-
tients for the expression of type I IFN genes. Compared to those
from apparently healthy subjects, AT patient fibroblasts had
constitutively elevated transcripts for type I IFN genes IFNB1
andMX1, as well as for the type III IFN gene IFN-l1 (IFNL1) (Fig-
ure 1E). Upon infection with VSV-GFP, AT fibroblasts were found
to elicit a higher IFNB1 response (Figure 1F) that correlated with
diminished viral replication and progeny virus production (Fig-
ures 1G and 1H). Notably, silencing of IFN-a and IFN-b receptor
(IFNAR1) by shRNA rendered AT patient fibroblastsmore permis-
sive to VSV infection (Figures 1I and 1J) emphasizing the impor-
tance of type I IFNs in observed resistance of AT patient cells to
VSV infection. To extend these findings, we also tested the
responsiveness of AT patient cells to the DNA virus, type I herpes
simplex virus (HSV1). Similarly, AT patient cells mounted a more
robust IFNB1 response and resistance to HSV1 replication (Fig-
ures 1K and 1L). Together these results demonstrate that ATM
dysfunction results in spontaneous type I IFN production which
primes cells for an amplified anti-viral innate immune response.
To further study this phenomenon, we resorted to Atm/
mice. Splenocytes (Figure S1A) and bone-marrow-derived mac-
rophages (BMDMs) (Figure S1B) from Atm/ mice showed
constitutive elevation of Ifnb1, Ifna4,Mx1 gene transcripts. Simi-
larly, transcripts for the IFN-inducible genes Irf7 and Sting
(Tmem173)-signaling molecules that are essential for an ampli-
fied type I IFN response (Honda et al., 2005; Ishikawa and
Barber, 2008) were elevated in Atm/ splenocytes and BMDMs
at steady state.
ATM Deficiency Primes the Type I IFN System
for Enhanced Anti-Microbial Response
To better monitor the IFN induction in vivo, ATM-deficient mice
were crossed with the sensitive IFN-b luciferase (Ifnb-luc) re-
porter mice (Lienenklaus et al., 2009). Whole-body photo imag-
ing revealed elevated systemic type I IFN response in Atm/
Ifnb+/Db-luc mice at steady state, as well as in response to VSV-
AV2 (Figure 2A). VSV-AV2, a natural variant of VSV, is defective
in its ability to inhibit anti-viral innate immunity and hence in-
duces elevated type I IFNs (Stojdl et al., 2003). Accordingly,
RT-PCR analysis revealed a stronger Ifnb1 and Mx1 responsein Atm/ BMDMs upon infection with VSV-AV2 (Figure 2B).
Such an elevated type I IFN response coincided with inhibited
replication and VSV-AV2 progeny production (Figures 2C and
2D). Further analysis of VSV RNA in splenocytes of mice infected
with VSV-GFP also revealed inhibited in vivo replication of VSV in
Atm/ mice (Figure 2E). To verify these results, we employed
lentiviral-mediated shRNA silencing of Atm in the murine RAW
264.7 macrophage cell line. Compared to control shRNAmacro-
phages, Atm-silenced RAW 264.7 macrophages exhibited
elevated Ifnb1 transcript level at steady state (Figures S2A and
S2B), recapitulating the situation observed in cells from AT pa-
tients or Atm/ mice. In line, flow cytometric analysis revealed
significantly inhibited replication of VSV-GFP in Atm silenced
macrophages (Figure S2C). Similarly, when infected with lucif-
erase reporter HSV1 (HSV1-luc) strain (Summers and Leib,
2002), Atm silenced cells exhibited decreased HSV1 replication
that coincided with enhanced Ifnb1 response (Figures S2D and
S2E). Together, these results indicate that loss of ATM results
in a primed innate immune system, which is more responsive
and hence protective against viral infection.
Next we asked whether loss of ATM also primes cells for
an amplified type I IFN induction in response to bacteria.
L. monocytogenes is a facultative intracellular Gram-positive
bacterium that triggers type I IFN response viamultiple PRRpath-
ways including TLRs and the cytoplasmic sensors for nucleic
acids and cyclic dinucleotides (RLRs, CDRs) (Abdullah et al.,
2012; Ishikawa et al., 2009; Woodward et al., 2010). Atm/
BMDMs were found to elicit a higher IFN-b -luciferase response
in response to L. monocytogenes infection (Figure S2F).
To elucidate which PRR pathways are primed by loss of
ATM, we stimulated BMDMs with defined ligands for different
PRRs including LPS (TLR4), Pam3CSK4 (TLR2), Poly(I:C)
(TLR3), and Poly(dA:dT) (RLRs, CDRs). Atm/ BMDMs elicited
higher IFN-b luciferase response to all such ligands (Figure S2F),
indicating that loss of ATM primes cells for an enhanced type I
IFN induction in response to TLRs, as well as cytoplasmic
PRRs.
ATM Deficiency Primes Cells for Enhanced Activation
of TBK1 upon Viral or Bacterial Challenge
TANK-binding kinase-1 (TBK1) is vital for activation of type I IFN
response downstream of many PRRs. Atm/ cells exhibited a
higher and more sustained activation of TBK1 and p38 mitogen-
activated protein kinase (p38 MAPK) upon L. monocytogenes
infection (Figures 3A and 3B). Similarly, Atm/ cells also ex-
hibited elevated activation of the NF-kB pathway as judged by
the faster rate of IkBa degradation (Figures 3A and 3B). Further
ablation of the IFN-a and -b receptor (IFNAR1) in the Atm/
background blunted the elevated proximal PRR signaling (Figures
3A and 3B) and Ifnb1, Ifna4, and Mx1 responses induced by
L. monocytogenes (Figure 3C), demonstrating that amplified
proximal PRR signaling and consequently type I IFN response
in Atm/ cells were due to the priming effect of spontaneously
produced type I IFNs.
We also extended these analyses to VSV-AV2 infection.
Atm/ BMDMs exhibited elevated activation of proximal PRR
signaling molecules including TBK1, p38 MAPK, and IRF3 (Fig-
ure 3D). Concomitantly, such cells displayed more a robust
type I IFN response and hence an inhibited replication ofImmunity 42, 332–343, February 17, 2015 ª2015 Elsevier Inc. 333
Figure 1. ATM Dysfunction in Humans Results in Elevated Spontaneous Type I IFN Response
(A andB) Sera fromAT patients protect against VSV infection. HEK293 cells pre-incubated for 12 hr with sera from apparently healthy subjects or AT patients were
infectedwith VSV-GFP (MOI 10), then analyzed for viral load by fluorescencemicroscopy (A) or flow cytometry (B) at 12 and 6 hr post infection, respectively. Insert
in B depicts corresponding median fluorescence intensity (MFI).
(C and D) Sera from AT patients induce type I IFN and NF-kB activities in target cells. Luciferase activity in HEK293-Mx-1 (C) and HEK293-NF-kB (D) luciferase
reporter cells incubated for 12 hr with sera from healthy subjects or AT patients (n = 4).
(E) qRT-PCR analysis of IFNB1, IFNL1, and MX1 mRNA in healthy and AT fibroblasts at steady state.
(F) qRT-PCR analysis of IFNB1 in healthy and AT fibroblasts infected (or not) with VSV-GFP (MOI 10) for 6 hr.
(G) Flow cytometric analysis of viral replication in healthy and AT fibroblasts infected with VSV-GFP for 6 hr. Insert depicts corresponding MFI.
(legend continued on next page)
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Figure 2. Loss of ATM Primes the Type I IFN System for an Enhanced Antiviral Innate Immunity
(A) Bioluminescence imaging of IFN-b luciferase response in representative pairs of Ifnb+/D-luc or Atm/Ifnb+/Db-luc mice at steady state and 6 hr post intra-
peritoneal infection with VSV-AV2 (2 3 107 pfu/mouse). The rainbow scale indicates the number of photons measured per second per cm2 per steradian (sr).
Quantification of fold change in IFN-b luciferase activity of Atm/Ifnb+/Db-luc mice in panel (A) compared to Ifnb+/Db-luc.
(B) qRT-PCR analysis of Ifnb1 and Mx1 mRNA in WT or Atm/ BMDMs 6 hr post infection (or not) with VSV-AV2 (MOI 1).
(C and D) qRT-PCR analysis of VSV RNA (C) and plaque forming assay in (D) BMDMs infected with VSV-AV2 (MOI 1) for the indicated time points.
(E) qRT-PCR analysis of VSV RNA in splenocytes of WT or Atm/mice 24 hr post infection with VSV-GFP. Results are representative of two to four independent
experiments. Data are shown asmean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001; (Student’s t test or one-way ANOVA followed by Bonferroni’s post-test). Also see
Figures S1 and S2.VSV-AV2 (Figures 3E and 3F). Importantly, additional ablation of
IFNAR in Atm/BMDMs resulted in more permissive replication
of VSV-AV2 (Figures 3E and 3F). All together, these data show
that loss of ATM results in a spontaneous production of type I
IFNs, which signal via IFNAR1 to prime cells for robust PRR
mediated anti-microbial response.(H) Plaque assay of VSV-GFP titer in culture supernatants of healthy and AT fibro
(I) qRT-PCR analysis of VSV-GFP RNA in healthy and AT fibroblasts transduced w
(J) Efficiency of IFNAR1 knockdown in human healthy and AT fibroblasts analyze
(K) qRT-PCR analysis of IFNB1 in healthy and AT fibroblasts infected with HSV1
(L) qRT-PCR estimation of HSV1 replication (RNA) in healthy and AT patients fibro
independent experiments. Data are shown as mean ± SEM. ***p < 0.001; (StudeDNA Damage Primes the Type I IFN System for an
Amplified IFN Response upon Microbial Challenge
To understand the mechanism underlying the amplified PRR
signaling and type I IFN responses in Atm/ cells, we asked
whether elevated type I IFN production inAtm/ cells was asso-
ciated with the loss of DNA repair. We reasoned that if elevatedblasts 12 hr post infection.
ith control (Ctrl) shRNA or IFNAR1 shRNA then infected with VSV-GFP for 6 hr.
d by qRT-PCR.
-luciferase (HSV1-luc) (MOI 1) for 6 hr.
blasts infected with HSV1-luc for 6 hr. Results are representative of two to three
nt’s t test or one-way ANOVA followed by Bonferroni’s post-test).
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Figure 3. Loss of ATM Primes Cells for Enhanced TBK1 Activation and Type I IFN Induction via IFNAR1
(A and B) Immunoblots (A) of p-TBK1, total TBK1, p-P38 MAPK, IkBa in WT, Atm/, Ifnar1/, and Atm/Ifnar1/ BMDMs infected with L. monocyogenes
(L.m.) (MOI 20) for the indicated time points. (B) Quantification of immunoblots in (A) normalized to a-Tubulin and presented as relative densities (pTBK1, p-p38) or
percentage of IkBa degradation compared to WT control.
(C) qRT-PCR analysis of Ifnb1, Ifna4, and Mx1 mRNA in WT, Atm/, Ifnar1/, and Atm/Ifnar1/ BMDMs infected with L.m. for 6 hr.
(D) Immunoblot analysis of p-TBK1, total TBK1, p-p38 MAPK, and p-IRF3 in WT, and Atm/ BMDMs infected with VSV-AV2 (MOI 10) for the indicated time
points.
(E) qRT-PCR analysis of Ifnb1 mRNA in WT, Atm/, Ifnar1/, and Atm/Ifnar1/ BMDMs infected with VSV-AV2 (MOI 1) for 12 hr.
(F) qRT-PCR analysis of viral RNA in BMDMs infected with VSV-AV2 for 12 hr. Results are representative of three independent experiments. Data are shown as
mean ± SEM. **p < 0.01, ***p < 0.001; (one-way ANOVA followed by Bonferroni’s post-test).type I IFN induction in Atm/ cells was due to accumulation of
unrepaired DNA lesions, then induction of DNA damage in
Atm+/+ BMDM should recapitulate the type I IFN phenotype
observed in Atm/ cells. Indeed, exposure of wild-type (WT)
BMDMs to g-irradiation or the DNA damaging agent etoposide
was found to induce Ifnb1, Ifna4,Mx1, Irf7, and Sting (Figure 4A),
as well as genes for several PRRs including Tlr4, Tlr2, Rig-I, the336 Immunity 42, 332–343, February 17, 2015 ª2015 Elsevier Inc.cytoplasmic DNA sensors cyclic GMP-AMP (cGAMP) synthase
(MB21D1/cGAS) and Ifi204 (human IFI16) (Figures S3A–S3C).
Upon further analysis, much like in Atm/ cells, as shown
above, WT BMDMs exposed to DNA damage were found to
be more responsive to the TLR ligands, LPS and Pam3CSK4,
the STING agonist c-di-GMP (Figure 4B), or infection by
L. monocytogenes or VSV-AV2 (Figure 4C). These results
Figure 4. DNA Damage Primes the Type I IFN System for an
Enhanced Induction of Type I IFNs
(A) qRT-PCR analysis of Ifnb1, Ifna4,Mx1, Irf7, and StingmRNA inWT BMDMs
6 hr after g-irradiation (5Gy).
(B) Luciferase activity in Ifnb+/Db-luc BMDMs primed (or not) by g-irradiation
(5Gy) as in (A) and then stimulatedwith LPS (500 ng/ml), Pam3CSK4 (100 ng/ml),
or stimulated with c-di-GMP (20 mg/ml) for 6 hr.
(C) qRT-PCR analysis of Ifnb1mRNA in WT BMDMs that were primed (or not)
by g-irradiation as in (A) and then infected with L.m. (MOI 20) or VSV-AV2 (MOI
1) for 6 hr. Results are representative of three independent experiments. Data
are shown asmean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001; (Student’s t test).
Also see Figure S3.indicate that DNA damage induces the expression of various
PRRs and downstream signaling partners such as IRF7 and
STING, which together might contribute to priming the innate im-
mune system for a rapid and amplified response upon microbial
challenge.
DNA Damage Primes the Type I IFN System via STING
TLRs, RLRs, and CDRs are the main PRRs for type I IFN induc-
tion. Hence, we wanted to determine the specific PRR pathways
involved in priming of the type I IFN system by DNA damage. To
this end, we analyzed g-irradiation-induced IFN-b luciferase
response in BMDMs from Ifnb+/Db-luc reporter mice deficient in
the TLR adaptors MYD88 and TICAM1 (also known as TRIF) or
the cytoplasmic DNA receptors STING. Whereas DNA damage
could activate IFN-b luciferase responses inMyd88/Ifnb+/Db-luc
and Ticam1
/
Ifnb+/Db-luc BMDMs, such a response was abro-
gated in Sting/Ifnb+/Db-luc BMDMs (Figure 5A). Myd88/,
Ticam1/, and Sting/ BMDMs, however displayed wild-type
g-H2A.X phophorylation upon g-irradiation (Figure 5B), indicating
that diminished type I IFN response in Sting/ cells was not due
to putative defects in DNA damage signaling. Next we asked
whether ablation of the STING pathway affects DNA damage-
induced priming of TLR signaling. In contrast to the Ifnb+/Db-luc,g-irradiated Sting/Ifnb+/Db-luc BMDMs did not show a signifi-
cantly enhanced IFN-b luciferase response upon Pam3CSK4 or
LPS stimulation (Figure 5C). Thus, DNA damage primes the
type I IFN system for enhanced TLR signaling via STING. Further-
more, similar to g-irradiation, etoposide treatment also primed
BMDMs for elevated IFN-b luciferase response (Figure 5D) and
TBK1 activation (Figure 5E) by L. monocytogenes in a STING
dependent manner. Much like in Atm/ cells, priming of the
type I IFN system by etoposide resulted in enhanced Ifnb1 tran-
scriptional response and inhibited replication of VSV (Figures
5F and 5G). Similarly, when challenged with HSV1, Atm/
BMDMs or WT BMDMs treated with etoposide mounted a higher
Ifnb1 transcriptional response and elevated TBK1 activation that
coincided with suppressed HSV1 replication (Figures S4A–S4D).
Mice triply deficient in MYD88, TICAM1, and IPS-1 (Myd88/
Ticam1/Ips-1/) are defective in all major PRR pathways for
type I IFN induction except the STING-dependent pathways.
To specifically analyze STING-dependent priming of the type I
IFN system by DNA damage, we g-irradiated and analyzed
Myd88/Ticam1/Ips-1/ BMDMs for type I IFN induction.
Indeed, g-irradiated Myd88/Ticam1/Ips-1/ BMDMs also
mounted a more robust Ifnb1 and Mx1 transcriptional response
upon infection with L. monocytogenes (Figure 5H). Consistent
with the type I IFN response, g-irradiation alone was found to
result in TBK1 activation in Myd88/Ticam1/Ips-1/
BMDMs, which was further amplified upon L. monocytogenes
infection (Figure 5I). Conversely, enhancement of TBK1 activa-
tion by g-irradiation was abrogated in Sting/ BMDMs (Fig-
ure S4E). Together, these observations indicate that DNA dam-
age primes the innate immune system for robust anti-microbial
response via the STING pathway.
Loss of ATM Primes the Type I IFN System via STING
Pathway
Next we sought to investigate whether the primed type I IFN state
caused by loss of ATM was also dependent on the STING
pathway. In this regard, we ask whether ablation of ATM in the
Myd88/Ticam1/Ips-1/ background could also result in
elevated type I IFN response at steady state, as well as in
response to infection. Therefore, we bred the Myd88/
Ticam1/Ips-1/ mice with Atm/ animals. In comparison to
those from Myd88/Ticam1/Ips-1/ mice, peritoneal cells
(PECs) from Atm+/Myd88/Ticam1/Ips-1/ mice displayed
higher Ifnb1 and Mx1 transcripts at steady state, as well as in
response to L. monocytogenes infection (Figure 6A). To unequiv-
ocally verifywhether the primed type I IFN systemcaused byATM
deficiency was dependent on the STING pathway, we generated
Ifnb+/Db-luc mice deficient in ATM and STING (Atm/Sting/
Ifnb+/Db-luc). Photo imaging of IFN-b luciferase activity of such
mice and the corresponding BMDMs (Figures 6B and 6D), as
well as ex vivo analysis of Ifnb1, Mx1, Irf7, and Sting transcripts
in splenocytes from such mice (Figure 6C) revealed that ablation
of the STING pathway could abrogate the elevated spontaneous
type I IFN response caused by loss of ATM. cGAS (Wu et al.,
2013) and IFI204 (human IFI16) (Jakobsen et al., 2013; Unterholz-
ner et al., 2010) are among the key DNA sensors upstream of
STING. Similar to ablation of STING, knockdown of cGas and
Ifi204 by shRNA greatly decreased type I IFN response caused
by ATM deficiency or the DNA damaging agent etoposideImmunity 42, 332–343, February 17, 2015 ª2015 Elsevier Inc. 337
Figure 5. DNA Damage Primes the Type I
IFN System via STING
(A) IFN-b luciferase response in Ifnb+/Db-luc,
Myd88/Ifnb+/Db-luc, Ticam1/Ifnb+/Db-luc,
Sting/Ifnb+/Db-lucBMDMs 6 hr after g-irradiation.
(B) Immunoblot analysis of g-H2A.X phosphory-
lation in WT, Myd88/, Ticam1/, and Sting/
BMDMs 1 hr after g-irradiation.
(C) IFN-b luciferase response in Ifnb+/Db-luc,Sting/
Ifnb+/Db-luc BMDMs primed (or not) by g-irradiation
for 6 hr and then stimulated with LPS (500 ng/ml)
or Pam3CSK4 (100 ng/ml) for 6 hr.
(D) IFN-b luciferase response in Ifnb+/Db-luc,Sting/
Ifnb+/Db-luc BMDMs pre-treated (or not) with
etoposide (50 mM) for 18 hr and then infected with
L.m. (MOI 20) for 3 hr.
(E) Immunoblot analysis of p-TBK1, p-g-H2A.X,
and total g-H2A.X in BMDMs pre-treated (or not)
with etoposide (50 mM) for 18 hr and then infected
with L.m. (MOI 20) for the indicated time points.
(F and G), qRT-PCR analysis of Ifnb1 (F) and VSV
RNA (G) in BMDMs pre-treated (or not) with eto-
poside (50 mM) for 18 hr and then infected with
VSV-GFP for 3 hr or the indicated time points.
(H) qRT-PCR analysis of Ifnb1 and Mx1 mRNA
in Myd88/Ticam1/Ips-1/ BMDMs primed
(or not) by g-irradiation (5Gy) and infected with
L.m. (MOI 20) for 6 hr.
(I) Immunoblot analysis of p-TBK1, p-p38 MAPK,
and p-g-H2A.X in Myd88/Ticam1/Ips-1/
BMDMs g-irradiated (or not) and then infected
with L.m. (MOI 20) for the indicated time points. *
highlights basal phosphorylation of TBK1 upon
g-irradiation. Results are representative of two to
three independent experiments. Data are shown
as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001;
(one-way ANOVA followed by Bonferroni post-test
or Student’s t test). Also see Figure S4.(Figures 6E–6H). Thus, much like DNA damage, loss of ATM
primes the type I IFN system via STING dependent mechanisms.
DNA Damage or Loss of ATM Releases ssDNA into
Cytoplasm thus Activating the STING Pathway
Accumulation of DNA in the cytoplasm as a result of replication
stress, DNA damage (Ahn et al., 2014; Yang et al., 2007), or repli-
cation intermediates of endogenous retroelements has previ-
ously been reported (Stetson et al., 2008). Therefore, to identify338 Immunity 42, 332–343, February 17, 2015 ª2015 Elsevier Inc.the endogenous molecules via which
loss of ATM or DNA damage primes the
type I IFN system, we analyzed cyto-
plasmic fractions for the presence of nu-
cleic acids. Cytoplasmic extracts (CytExt)
from Atm/ BMDMs (Atm/CytExt) or
g-irradiated WT BMDMs (WT/5Gy Cy-
tExt) were found to be enriched in nucleic
acids. Upon further analysis, such CytExt
DNA was found to be highly sensitive to
ssDNA degrading enzyme S1 nuclease,
but showed moderate sensitivity to
DNase I, which degrades dsDNA (Figures
7A–7C). Thus, whereas amajor fraction ofDNA released into the cytoplasm upon DNA damage might be
ssDNA, it appears that dsDNA also contributes. To study ssDNA
in a more specific manner, we stained cytoplasm of WT and
Atm/ BMDMs with anti-ssDNA antibody and analyzed by
flow cytometry. Atm/ BMDMs showed positive staining for
ssDNA that was sensitive to S1 nuclease treatment (Figure 7D).
Immunofluoresence microscopic analysis also confirmed accu-
mulation of ssDNA in Atm/ BMDMs, as well as in fibroblasts
from AT patients (Figures 7E and 7F).
Figure 6. Loss of ATM Primes the Type I IFN
System via STING
(A) qRT-PCR analysis of Ifnb1 and Mx1 in peri-
toneal cells isolated from Myd88/Ticam1/
Ips-1/ and Atm+/Myd88-/ Ticam1/Ips-1/
mice infected (or not) with L.m. (105 cfu /mouse) for
6 hr.
(B) In vivo photo imaging and correspond-
ing spontaneous IFN-b luciferase activities in
Ifnb+/Db-luc, Atm/Ifnb+/Db-luc, Sting/Ifnb+/Db-luc,
Atm/Sting/Ifnb+/Db-luc mice. Luciferase
expression is represented by a color shift from blue
to red. Graph depicts corresponding fold change in
IFN-b luciferase activity relative to Ifnb+/Db-luc.
(C) qRT-PCR analysis of Ifnb, Mx1, Irf7, and Sting
mRNA in splenocytes from WT, Atm/, Sting/,
and Atm/Sting/ mice at steady state.
(D) Photo imaging of spontaneous IFN-b-luc
response in BMDMs from Ifnb+/Db-luc, Atm/
Ifnb+/Db-luc, Sting/Ifnb+/Db-luc, and Atm/
Sting/Ifnb+/Db-luc mice. Graph depicts corre-
sponding fold change in IFN-b luciferase activities
relative to WT BMDMs.
(E) qRT-PCR analysis of Ifnb1mRNA in RAW264.7
macrophages silenced by shRNA for Atm, cGas,
or both (shRNA Atm + cGAS).
(F) qRT-PCR analysis of Ifnb1mRNA in RAW264.7
macrophages shRNA silenced for Atm, Ifi204, or
both (shRNA Atm + Ifi204).
(G) qRT-PCR analysis of Ifnb1 mRNA in RAW
264.7 macrophages silenced by shRNA for cGAS
or Ifi204 then stimulated (or not) with etoposide
(50 mM) for 18 hr.
(H) shRNA knockdown efficiency of Atm, cGAS
and Ifi204 in silenced RAW macrophages used in
(E) and (F), as revealed by qRT-PCR. Results are
representative of two to three independent ex-
periments. Data are shown as mean ± SEM. **p <
0.01, ***p < 0.001; (one-way ANOVA followed by
Bonferroni’s post-test or Student’s t test).Spontaneous accumulation of ssDNA and a concomitant Ifnb1
induction was also evident in RAW 264.7 macrophages in which
Atm was ablated by shRNA Atm (Figures S5A–S5C). Remark-
ably, further silencing of Sting in such cells (shRNA Atm and
Sting) abrogated elevated Ifnb1 transcriptional response, but
not cytoplasmic ssDNA levels, indicating that diminished IFN
response in cells doubly deficient in ATM and STING was due
to defective recognition of cytoplasmic DNA and not DNA
release into the cytoplasm (Figures S5A and S5B).
The exonuclease Trex1 is essential for clearance of DNA from
the cytoplasm, hence its deficiency results in type I IFN driven
autoimmunity syndromes (Crow and Rehwinkel, 2009; Gall
et al., 2012; Stetson et al., 2008; Yang et al., 2007). In addition
to a steady-state expression, Trex1 has previously been shownImmunity 42, 332–343,to be induced by interferon-stimulatory
DNA (Stetson et al., 2008). Consistently,
Trex1 transcripts were found upregulated
in Atm/ BMDMs and Atm shRNA
silenced RAW 264.7 macrophages at
steady state, as well as in response to
VSV infection in a STING-dependentmanner (Figures S6A and S6D), suggesting that Trex1 is an
inflammation-inducible gene activated possibly to enable the
cell cope with extraneous DNA in the cytoplasm. Thus, to further
support the idea that the observed type I IFN phenotype was due
to accumulation of DNA in cytoplasm of ATM deficient cells, we
asked whether silencing of Trex1 (shRNA Trex1) would augment
the accumulation of cytoplasmic ssDNA and hence accentuate
the spontaneous type I IFN response in Atm silenced cells
(shRNA Atm). Indeed, ablation of Trex1 in Atm silenced RAW
264.7 macrophages (shRNA Atm and Trex1) boosted accumula-
tion of ssDNA in the cytoplasm (Figure S6B) and amplified spon-
taneous type I IFN response (Figures S6C and S6D). To further
explore, by quantitative PCR analysis, we evaluated whether
endogenous retroelements also accumulate in the cytoplasmFebruary 17, 2015 ª2015 Elsevier Inc. 339
Figure 7. DNA Damage or Loss of ATM Re-
sults in Accumulation of DNA in the Cyto-
plasm thus Activating the STING Pathway
(A) Agarose gel analysis of cytoplasmic extracts
(CytExt) from WT BMDMs (WT CytExt), Atm/
BMDMs (Atm/ CytExt) at steady state or 3 hr
after g-irradiation (5Gy) of WT BMDMs (WT/5Gy
CytExt). CytExt were treated (or not) with S1
nuclease.
(B) Purity of sub-cellular fractions as determined
by immunoblotting for g-H2A.X and a-Tubulin in
cytoplasmic fractions (CF) depicted in (A) and
corresponding nuclear fraction (NF) and whole cell
lysates (WCL).
(C) Agarose gel analysis of WT/5Gy CytExt, ssDNA
controls ssDNA 110, self-annealing ssDNA 110, or
plasmid DNA treated (or not) with S1 nuclease
(5 U/ml), DNase I (0.01 U/ml). White arrow in panel
(C) indicates the self-annealed dsDNA of self-an-
nealing ssDNA 110.
(D) Flow cytometry analysis of methanol fixed WT,
Atm/ BMDMs treated (or not) with S1-nuclease
and then stained with anti-ssDNA Alexa Fluor 488.
(E and F) Immunofluoresence microscopic anal-
ysis of ssDNA (green) in WT and Atm/ BMDMs
(E) or fibroblasts from healthy and AT patients (F).
(G) STING staining in WT, Atm/, Sting/
BMDMs at steady state or in WT BMDMs treated
with etoposide for 18 hr or transfected with WT
CytExt or Atm/ CytExt. STING was stained us-
ing anti-STING/Alexa Fluor 488 conjugated sec-
ondary antibody (green) and DAPI (blue) for nuclei.
(H) WT CytExt and Atm/ CytExt were trans-
fected into Ifnb+/Db-luc or Sting/Ifnb+/Db-luc
macrophages and IFN-b induction was deter-
mined by luciferase assay and qRT-PCR. Data are
representative of three independent experiments.
Quantitative measurements are shown as mean ±
SEM. Also see Figures S5–S7.of Atm/ cells or upon DNA damage. Retrotransposon-like 1
(Rtl1) was found to be enriched in Atm/ CytExt and WT/5Gy
CytExt (Figure S6E). Thus in addition to leakage from the nu-
cleus, activation of endogenous retroelements might in part
contribute to the observed accumulation of DNA in the cyto-
plasm upon DNA damage.
Triggering of cytoplasmic DNA receptors is associated with
intracellular clustering of STING (Ahn et al., 2012; Ishikawa
et al., 2009). In agreement with the above data, clustering of
STING was discernible at steady-state conditions in Atm/
BMDMs, as well as in WT BMDMs treated with etoposide (Fig-
ure 7G). Upon transfection, Atm/ CytExts, but not WT Cy-
tExts, could induce STING clustering (Figure 7G) and activate
IFN-b luciferase response in a STING-dependent manner (Fig-
ure 7H). Notably, consistent with an abundance of ssDNA, incu-
bation with S1 nuclease effectively abrogated the type I IFN340 Immunity 42, 332–343, February 17, 2015 ª2015 Elsevier Inc.stimulatory activity of WT/5Gy CytExt
DNA. On the other hand DNase I had a
moderate but significant effect, support-
ing the notion that dsDNA does also
partially contribute to the observed re-
sponses (Figure S7). Together these re-sults indicate that DNA damage results in release of DNA in
the cytoplasm where it activates the STING pathway to prime
the innate immune system.
DISCUSSION
Constitutive production of type I IFNs is vital for immune homeo-
stasis and for maintaining the innate immune system stirred up
for prompt response to microbial and other environmental
danger signals. The cell-intrinsic molecular events that trigger
constitutive type I IFN production are unclear. In this study we
show that DNA damage plays an important role in priming the
type I IFN system. Consequently, DNA damage or loss of the
DNA repair kinase ATM culminates in enhanced constitutive pro-
duction of type I IFNs, elevated expression of different PRRs and
their downstream signaling partners, which together may
contribute to prime the innate immune system for a swift and
amplified response upon microbial encounter.
Through crosses with a variety of mice defective in different
PRR signaling pathways, we show that such priming is due to
the activation of the STING pathway by DNA released into the
cytoplasm upon DNA damage. A number of molecules including
DAI, DHX9, DHX36, IFI204 (IFI16), DDX41, DXX60, Pol III,
LRRFIP1, DNA-PK, and most recently cGAS (Wu et al., 2013)
and the DNA repair protein Mre11 (Kondo et al., 2013) have
been proposed as direct cytoplasmic DNA sensors that act up-
stream of STING to induce type I IFNs (for review, see Paludan
and Bowie [2013]). Our results indicate a role for cGAS and
IFI204 in DNA damage mediated type I IFN induction. However,
it is also conceivable that multiple receptors, most likely acting in
a redundant and cell-type-specific manner, might contribute to
the recognition of cytoplasmic DNA resulting from DNA lesions.
Activation of the type I IFN systemby self-DNA has been linked
to the etiology of variety of inflammatory diseases. Notably,
accumulation of cytoplasmic ssDNA due to defects in the DNA
exonuclease TREX1 (Stetson et al., 2008), or the 30 exonuclease
and deoxynucleotide (dNTP) triphosphohydrolase SAMHD1
(Behrendt et al., 2013; Tu¨ngler et al., 2013) has been linked to Ai-
cardi-Goutie`res syndrome (AGS). AGS is a neurodegenerative
and inflammatory disease that mimics congenital viral infection
and which phenotypically overlaps with the autoimmune disease
systemic lupus erythematosus (Gall et al., 2012; Rice et al.,
2007). Correspondingly, while stereotyped as a neurodegenera-
tive disease, AT manifests a variety of inflammatory phenotypes
including increased risk to cardiovascular diseases, type 2 dia-
betes, arthritis, colitis, multiple sclerosis, and autoimmunity (Am-
mann and Hong, 1971; Deng et al., 2005; Kutukculer and Aksu,
2000; Meyts et al., 2003; Shao et al., 2009; Westbrook and
Schiestl, 2010). Remarkably, the major cause of mortality and
morbidity in AT patients is pulmonary insufficiency due to recur-
rent respiratory bacterial infections. Oddly, severe viral infections
are uncommon in such patients. Recent clinical studies have
shown that AT patients have systemic inflammation (McGrath-
Morrow et al., 2010; Nowak-Wegrzyn et al., 2004; Schroeder
and Zielen, 2013) and that anti-inflammatory medication rather
than antibiotic treatment could suppress or even reverse lung
deterioration in AT patients (Schroeder and Zielen, 2013).
Clear-cut benefits of anti-inflammatory based therapy on pro-
gression of neurodegeneration in AT have also been reported
(Giardino et al., 2013). Similarly, inhibition of ATM was recently
shown to result in uncontrolled inflammatory response by glial
cells, in turn driving neurodegeneration in Drosophila (Petersen
et al., 2012). Together, these increasing pieces of evidence
buttress a hitherto underappreciated role of inflammation in the
clinical manifestations of AT and proposes a mechanistic expla-
nation for the disproportionate rarity of severe viral infections in
such patients.
Finally and more broadly, the present findings establish a role
of DNA damage in reviving up the innate immune system for
enhanced anti-microbial innate immune responses. Conse-
quently, tampering with DNA damage repair machinery, such
as a kinase ATM, results in spontaneous production of type I
IFNs which while priming the innate immune system for a robust
anti-viral defense might on the other hand contribute to unwar-
ranted inflammation, much to the host’s detriment. Thus thetype I IFN system under normal homeostatic conditions appears
to be well balanced between priming and inflammation.
EXPERIMENTAL PROCEDURES
Ethics Statement
Experiments involving human subjects were done according to the recom-
mendations of the local Research Ethics Committee of Umea˚ University
(Regionala etikpro¨vningsna¨mnden i Umea˚) Sweden, as approved in permit
Dnr 2012-501-31M. Fully informed consent was obtained from healthy and
AT patients, in compliance with the Declaration of Helsinki. All mice weremain-
tained under specific pathogen free conditions and experiments were
approved and carried out according to the guidelines set out by the Regional
Animal Ethic Committee Approval #A107-11 or A126-12.
In Vivo Animal Experiments
In vivo infection experiments were performed in Umea˚ Center for Comparative
Biology (UCCB). An intraperitoneal (IP) dose of 105 cfu was used for
L. monocytogenes infection. An IP dose of 23 107 pfu was used for VSV infec-
tions. Mice were anaesthetized using isoflurane in the XGI-8 gas anesthesia
system (Caliper), injected with firefly luciferin then analyzed using the IVIS-
200 system (Caliper). The software Living Image 3.0 (Caliper) was used for im-
age analysis and quantification of emission intensities.
Cell Culture, Viruses, Stimulation, Transfection, and g-Irradiation
HEK293 cells, RAW 264.7 macrophages and human healthy (GM05294, Coriell
Institute for Medical Research) and AT patient fibroblasts (GM02052, Coriell
Institute for Medical Research) were maintained in DMEM containing 10%
(v/v) Fetal Calf Serum (FCS, Hyclone). Bone-marrow-derived macrophages
(BMDMs) were generated by culturing the mouse bone marrow cells in IMDM
medium (GIBCO, Life Technologies) supplemented with 10% FCS (GIBCO,
Life Technologies), 100 U/ml penicillin (Sigma-Aldrich), and 100 g/ml strepto-
mycin (Sigma-Aldrich), 2 mM glutamine (Sigma-Aldrich) and 20% (v/v) L929
conditional medium. BMDMs were either stimulated with LPS (500 ng/ml),
Pam3CSK4 (100or 200 ng/ml), Poly(I:C) (30mg/ml), c-di-GMP (20mg/ml), Listeria
monocytogenes EGD-e at a multiplicity of infection (MOI 20), VSV-GFP (Boritz
et al., 1999) (MOI 1 or 10), VSV-AV2 (Stojdl et al., 2003) (MOI 1 or 10), or HSV
type 1 strain KOS KOS/Dlux/OriL (HSV1-luc) (Summers and Leib, 2002) (MOI
0.1 or 1). Poly(dA:dT) (1 mg/ml) and isolated cytoplasmic DNA from WT,
Atm/ cells were transfected into macrophages using Lyovec according to
manufacturer’s instructions (Invivogen). BMDMs were g-irradiated with a
dose of 5Gy using Gammacell 40 irradiator (MDS Nordion).
Immunofluorescence Microscopy
Cells cultured on coverslipswere fixedwith 4% (w/v) paraformaldehyde in PBS
for 15 min, permeabilized with 0.2% (v/v) Triton X-100, blocked with 3% (w/v)
BSA in PBS for 30 min, and then incubated with primary antibodies containing
1% (w/v) BSA and 0.1% (w/v) saponin in PBS for 1 hr, washed with PBS then
incubated with anti-rabbit IgG or anti-mouse IgM Alexa 488 fluorescence sec-
ondary antibodies for 1 hr, respectively. Following washing, cells were stained
with DAPI, washed with PBS, and mounted onto microscope slides and
imaged using a NIKON C1 confocal microscope.
FACS Analysis of ssDNA
BMDMs were fixed in 80% methanol in PBS, ± 150 mM NaCl, without further
treatment prior to adding antibody. Cells were pretreated with 200 U/ml S1
nuclease (Invitrogen) at 37C for 1 hr as indicated. FACS analysis of ssDNA-
labeled cells were performed and analyzed by a Becton Dickinson FACSCali-
bur flow cytometer.
Purification of Cytoplasmic DNA
Cytoplasmic extract (CytExt) was isolated as previously described with minor
modifications (Yang et al., 2007). Briefly, WT, WT + 5Gy g-irradiated, and
Atm/ BMDMs were lysed in 10 mM HEPES (pH 7.9), 10 mM KCl, 1.5 mM
MgCl2, 0.34 M sucrose, 10% (v/v) glycerol, plus protease inhibitors for 5 min
on ice with 0.1% (v/v) Triton X-100, and nuclei were removed by low-speed
centrifugation (1,500 3 g, 10 min). Cytoplasmic protein extracts were treatedImmunity 42, 332–343, February 17, 2015 ª2015 Elsevier Inc. 341
with 1 mg/ml Proteinase K at 55C for 1 hr. After phenol/chloroform extraction,
the aqueous supernatant was incubated with 500 mg/ml DNase-free RNase A
(QIAGEN) for 30 min at 37C, again followed by phenol/chloroform extraction.
The DNA-containing aqueous phase was precipitated, resuspended in TE
buffer, DNA concentrations were adjusted to the protein concentration of cyto-
plasmic fractions and analyzed by a 2% (w/v) agarose gel in 1 3 TBE buffer
with 1 3 GelRed stain (Biotium, Madison, WI) incorporated in gel.
Statistical Analysis
All data are shown as mean ± SEM. Statistical analysis was performed using a
two-tailed Student’s t test or analysis of variance (ANOVA) test followed by
Bonferroni’s post hoc test. For all tests, p values less than 0.05 were consid-
ered statistically significant.
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